Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by HSI-HSIEN HSU
Lauric Acid Can Improve the Sensitization of Cetuximab in KRAS/BRAF Mutated Colorectal Cancer Cells by Retrievable microRNA-378 Expression
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
T Cell-Engaging BiTE Antibodies Specific for EGFR Potently Eliminate KRAS- And BRAF-mutated Colorectal Cancer Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Frontiers in Oncology
Cancer Research
Oncology
BRAF-mutated Metastatic Colorectal Cancer Between Past and Future
British Journal of Cancer
Cancer Research
Oncology
Mutation Pattern of KRAS and BRAF Oncogenes in Colorectal Cancer Patients
Neoplasma
Cancer Research
EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy
Cancers
Cancer Research
Oncology
Molecular Pathological Epidemiology of Colorectal Cancer in Chinese Patients With KRAS and BRAF Mutations
Oncotarget
Oncology
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- And PIK3CA- Wild-Type Metastatic Colorectal Cancer: The AGITG Randomised Phase II ICECREAM Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
MicroRNA-18a Upregulates Autophagy and Ataxia Telangiectasia Mutated Gene Expression in HCT116 Colon Cancer Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Concomitant Inhibition of Receptor Tyrosine Kinases and Downstream AKT Synergistically Inhibited Growth of KRAS/BRAF Mutant Colorectal Cancer Cells
Oncotarget
Oncology
